» Articles » PMID: 35317269

Mechanisms of AMPA Receptor Inhibition by Diminazene

Overview
Publisher Springer
Date 2022 Mar 23
PMID 35317269
Authors
Affiliations
Soon will be listed here.
Abstract

Diminazene is an anti-infection agent for animals and is a member of the diarylamidine group. This study reports the first detection of its inhibitory effect on AMPA-type ionotropic glutamate receptors. Experiments were carried out on isolated Wistar rat neurons: striatal giant cholinergic interneurons were used to study calcium-permeable AMPA receptors and hippocampal field CA1 pyramidal neurons were used to study calcium-impermeable AMPA receptors. Cells were isolated by vibrodissociation and currents were recorded by voltage clamping in the whole cell configuration. Diminazene produced concentration-dependent inhibition of currents evoked by application of kainate in both neuron types. IC values for calcium-permeable and calcium-impermeable AMPA receptors were 60 ± 11 and 160 ± 30 μM, respectively. Of note is that the inhibitory action of diminazene increased with increases in agonist concentration. The plot of the voltage dependence of inhibition at a fixed diminazene concentration for calcium-permeable AMPA receptors was biphasic: minimal inhibition was seen at positive potentials and maximum at -40 to -60 mV, while further hyperpolarization produced a gradual decrease in blockade efficacy. All these properties provide evidence that diminazene blocks AMPA receptor channels, perhaps with penetration through channels into cells.

Citing Articles

Diarylamidine activation of a brachiopod DEG/ENaC/ASIC channel.

Marti-Solans J, Borve A, Hejnol A, Lynagh T J Biol Chem. 2024; 301(1):108066.

PMID: 39662830 PMC: 11750451. DOI: 10.1016/j.jbc.2024.108066.


The diversity of AMPA receptor inhibition mechanisms among amidine-containing compounds.

Zhigulin A, Dron M, Barygin O, Tikhonov D Front Pharmacol. 2024; 15:1467266.

PMID: 39444609 PMC: 11496081. DOI: 10.3389/fphar.2024.1467266.


Diversity of AMPA Receptor Ligands: Chemotypes, Binding Modes, Mechanisms of Action, and Therapeutic Effects.

Golubeva E, Lavrov M, Radchenko E, Palyulin V Biomolecules. 2023; 13(1).

PMID: 36671441 PMC: 9856200. DOI: 10.3390/biom13010056.

References
1.
Donevan S, Rogawski M . GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 1993; 10(1):51-9. DOI: 10.1016/0896-6273(93)90241-i. View

2.
Eldefrawi A, Eldefrawi M, Konno K, Mansour N, Nakanishi K, Oltz E . Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. Proc Natl Acad Sci U S A. 1988; 85(13):4910-3. PMC: 280547. DOI: 10.1073/pnas.85.13.4910. View

3.
Mellor I, Usherwood P . Targeting ionotropic receptors with polyamine-containing toxins. Toxicon. 2004; 43(5):493-508. DOI: 10.1016/j.toxicon.2004.02.003. View

4.
Tikhonov D, Samoilova M, Buldakova S, Gmiro V, Magazanik L . Voltage-dependent block of native AMPA receptor channels by dicationic compounds. Br J Pharmacol. 2000; 129(2):265-74. PMC: 1571829. DOI: 10.1038/sj.bjp.0703043. View

5.
Dron M, Zhigulin A, Barygin O . Mechanisms of NMDA receptor inhibition by diarylamidine compounds. Eur J Neurosci. 2019; 51(7):1573-1582. DOI: 10.1111/ejn.14589. View